BioNexus Gene Lab Corp.
BGLC | NASDAQ
$1.48
-$0.02 (-1.33%)
Sep 22, 2026, 11:47 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 76.16K | 22.84K | 483.76K | 2.54M | 2.26M | 2.14M | 2.52M | 2.63M | 1.97M | 2.38M | 2.27M | 2.55M | 2.57M | 2.38M | 2.84M | 2.58M | 2.49M | 3.03M | 3.25M | 3.58M | 3.09M | 3.45M |
Cost of Revenue | 63.17K | 45.57K | 487.74K | 2.17M | 1.89M | 1.79M | 2.21M | 2.3M | 1.69M | 2.02M | 2.01M | 2.2M | 2.23M | 2.01M | 2.5M | 2.28M | 2.24M | 2.7M | 2.79M | 2.89M | 2.62M | 2.87M |
Gross Profit | 12.98K | -22.73K | -3.98K | 377.69K | 368.02K | 343.49K | 309.23K | 326.54K | 288.72K | 365.03K | 266.56K | 354.33K | 339.71K | 368.9K | 339.23K | 299.5K | 243.32K | 333.54K | 455.55K | 688.1K | 467.61K | 582.57K |
Operating Income | -282.4K | -571.43K | -1.03M | -702.51K | -611.29K | -618.42K | -416.22K | -1.34M | 259.17K | -79.03K | 256.71K | -2.53M | -272.2K | -50.63K | -122.69K | -65.22K | -137.96K | 34.69K | 201.06K | 372.64K | 139.99K | 342.1K |
Interest Income | 21.18K | 17.18K | 9.77K | 20.78K | 29.77K | 23.57K | 147.64K | n/a | n/a | 28.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -286.45K | -543.58K | -1.04M | -708.99K | -616.17K | -623.33K | -422.03K | -1.34M | 254.69K | -83.69K | 252.53K | -2.53M | -275.24K | -53.08K | -127.45K | -67.29K | -140.28K | 31.37K | 197.08K | 370.49K | 136.54K | 338.74K |
Net Income | -286.45K | -543.58K | -1.04M | -708.99K | -616.17K | -623.33K | -348.32K | -1.35M | 199.1K | -103.76K | 307.42K | -2.61M | -259.25K | -69.07K | -156.97K | -77.4K | -138.66K | 17.07K | 89.24K | 295.32K | 28.26K | 338.74K |
Selling & General & Admin | 334.55K | 534.22K | 1.01M | -105.88K | 1.13M | -148.82K | 469.4K | 2.13M | 759.66K | 469.67K | -15.91K | 3.08M | 807.08K | 536.87K | 487.86K | 418.82K | 434.12K | 345.24K | 161.21K | 362.31K | 378.05K | 302.85K |
Research & Development | 13.67K | 14.49K | 11.1K | 14.88K | 12.56K | 12.14K | 47.51K | n/a | 8.2K | 11.48K | 54.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -52.84K | n/a | 5.41K | 1.17M | -158.46K | 1.1M | 208.54K | -465.53K | -738.3K | -37.08K | -29.23K | -198.24K | -195.16K | -117.34K | -25.94K | -54.11K | -52.84K | -46.39K | 93.27K | -46.85K | -50.43K | -62.39K |
Operating Expenses | 295.38K | 548.7K | 1.03M | 1.08M | 979.32K | 961.91K | 725.45K | 1.66M | 29.55K | 444.06K | 9.85K | 2.88M | 611.91K | 419.53K | 461.92K | 364.71K | 381.29K | 298.85K | 254.49K | 315.46K | 327.62K | 240.46K |
Interest Expense | n/a | 3.09K | 3.27K | n/a | 4.88K | 4.91K | 5.81K | 6.19K | 4.48K | 4.66K | 4.18K | 4.26K | 3.04K | 2.45K | 4.76K | 2.07K | 2.32K | 3.33K | 3.99K | 2.15K | 3.45K | 3.36K |
Selling & Marketing Expenses | 36.02K | n/a | 35.64K | -551.57K | 608.43K | -540.7K | 2.03M | n/a | n/a | 153.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 358.55K | 594.28K | 1.52M | 3.25M | 2.87M | 2.76M | 2.94M | 3.97M | 1.72M | 2.46M | 2.02M | 5.08M | 2.84M | 2.43M | 2.96M | 2.64M | 2.62M | 2.99M | 3.04M | 3.2M | 2.95M | 3.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -73.71K | 1.56K | 55.58K | 20.07K | -54.89K | 76.42K | -15.99K | 15.99K | 29.52K | 10.11K | -1.62K | 14.3K | 107.83K | 75.17K | 108.28K | n/a |
Shares Outstanding (Basic) | 2.42M | 2.42M | 1.86M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 1.77M | 1.77M | 1.77M | 1.68M | 1.45M | 1.45M | 1.45M | 1.44M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
Shares Outstanding (Diluted) | 2.42M | 2.42M | 1.86M | 1.8M | 1.8M | 1.8M | 1.8M | 1.8M | 1.77M | 1.77M | 1.77M | 1.68M | 1.45M | 1.45M | 1.45M | 1.45M | 1.44M | 1.43M | 1.43M | 1.43M | 1.43M | 1.43M |
EPS (Basic) | -0.12 | -0.22 | -0.53 | -0.39 | -0.34 | -0.35 | -0.19 | -0.75 | 0.11 | -0.06 | 0.17 | -1.56 | -0.02 | 0 | -0.01 | -0.01 | -0.01 | 0 | 0.01 | 0.02 | 0 | 0.02 |
EPS (Diluted) | -0.12 | -0.22 | -0.53 | -0.39 | -0.34 | -0.35 | -0.19 | -0.75 | 0.11 | -0.06 | 0.17 | -1.56 | -0.02 | 0 | -0.01 | -0.01 | -0.01 | 0 | 0.01 | 0.02 | 0 | 0.02 |
EBITDA | -286.45K | -496.61K | -989.65K | -665.64K | -569.56K | -546.92K | -373.2K | -1.29M | 290.63K | -49.44K | 286.36K | -2.5M | -247.59K | -25.76K | -96.63K | -39.38K | -111.08K | 61.34K | 227.58K | 399.46K | 179.82K | 357.16K |
EBIT | -286.45K | -540.49K | -1.03M | -708.99K | -611.29K | -586.94K | -416.22K | -1.34M | 259.17K | -79.03K | 256.71K | -2.53M | -272.2K | -50.63K | -122.69K | -65.22K | -137.96K | 34.69K | 201.06K | 372.64K | 139.99K | 342.1K |
Depreciation & Amortization | n/a | 43.88K | 43.2K | 43.36K | 41.73K | 40.02K | 43.03K | 49.08K | 31.46K | 29.59K | 29.66K | 29.29K | 24.61K | 24.87K | 26.06K | 25.83K | 26.88K | 26.65K | 26.52K | 26.82K | 39.83K | 15.06K |
Add to Watchlist
Select watchlists to add or remove BGLC